Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guillaume Aussedat

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Blood|January 12, 2019
One translocation for 2 lymphoid neoplasmsGuillaume Aussedat, Lucile Baseggio
Annales De Biologie Clinique|June 29, 2022
Lymphoma diagnosis: lessons learned from the comparison of histology and cytology associated with flow cytometryGuillaume Aussedat, Juliette Fontaine, Luc-Marie Gerland, et al.
Frontiers in Oncology|November 15, 2024
End-of-life management of multiple myeloma patients in the era of CD38 and immunotherapyPierre Sesques, Lionel Karlin, Emmanuel Massy, et al.
Hematological Oncology|July 11, 2024
Evaluation of participation and recruitment bias in a prospective Real World Data in Lymphoma and Survival in Adults (REALYSA) cohort for newly diagnosed lymphoma patients over 1 year in a hematology department of teaching hospitalCaroline Le Lan, Aurélien Belot, Camille Golfier, et al.
Leukemia & Lymphoma|November 1, 2021
Rituximab in combination with adapted-dose of ifosfamide and etoposide as salvage treatment in elderly refractory/relapsed diffuse large B-cell lymphoma patients non-candidate for high dose therapy: a retrospective studyGuillaume Aussedat, Delphine Maucort-Boulch, Philippe Rey, et al.
Blood Advances|April 19, 2022
HLA-DR expression on monocytes and outcome of anti-CD19 CAR T-cell therapy for large B-cell lymphomaEstelle Bourbon, Pierre Sesques, Morgane Gossez, et al.
British Journal of Haematology|February 8, 2020
Composite and sequential lymphoma between classical Hodgkin lymphoma and primary mediastinal lymphoma/diffuse large B-cell lymphoma, a clinico-pathological series of 25 casesGuillaume Aussedat, Alexandra Traverse-Glehen, Aspasia Stamatoullas, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Blood|January 12, 2019
One translocation for 2 lymphoid neoplasmsGuillaume Aussedat, Lucile Baseggio
Annales De Biologie Clinique|June 29, 2022
Lymphoma diagnosis: lessons learned from the comparison of histology and cytology associated with flow cytometryGuillaume Aussedat, Juliette Fontaine, Luc-Marie Gerland, et al.
Frontiers in Oncology|November 15, 2024
End-of-life management of multiple myeloma patients in the era of CD38 and immunotherapyPierre Sesques, Lionel Karlin, Emmanuel Massy, et al.
Hematological Oncology|July 11, 2024
Evaluation of participation and recruitment bias in a prospective Real World Data in Lymphoma and Survival in Adults (REALYSA) cohort for newly diagnosed lymphoma patients over 1 year in a hematology department of teaching hospitalCaroline Le Lan, Aurélien Belot, Camille Golfier, et al.
Leukemia & Lymphoma|November 1, 2021
Rituximab in combination with adapted-dose of ifosfamide and etoposide as salvage treatment in elderly refractory/relapsed diffuse large B-cell lymphoma patients non-candidate for high dose therapy: a retrospective studyGuillaume Aussedat, Delphine Maucort-Boulch, Philippe Rey, et al.
Blood Advances|April 19, 2022
HLA-DR expression on monocytes and outcome of anti-CD19 CAR T-cell therapy for large B-cell lymphomaEstelle Bourbon, Pierre Sesques, Morgane Gossez, et al.
British Journal of Haematology|February 8, 2020
Composite and sequential lymphoma between classical Hodgkin lymphoma and primary mediastinal lymphoma/diffuse large B-cell lymphoma, a clinico-pathological series of 25 casesGuillaume Aussedat, Alexandra Traverse-Glehen, Aspasia Stamatoullas, et al.
Pageof 1